Difference between revisions of "Prieto-Vila M, et al. Int. J. Mol. Sci. (2017) cited as Ref 645 in DOI: 10.1038/s41392-020-0110-5 (Q9908)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 2574-, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fifth Author string (P153): Ochiya T, #quickstatements; #temporary_batch_1590155508986) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / Fourth Author string | |||
| + | Kohama I | ||
| Property / Fourth Author string: Kohama I / rank | |||
| + | Normal rank | ||
| Property / Fifth Author string | |||
| + | Ochiya T | ||
| Property / Fifth Author string: Ochiya T / rank | |||
| + | Normal rank | ||
Latest revision as of 13:53, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Prieto-Vila M, et al. Int. J. Mol. Sci. (2017) cited as Ref 645 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Prieto-Vila M
0 references
Takahashi RU
0 references
Usuba W
0 references
2017
0 references
Int. J. Mol. Sci.
0 references
18
0 references
Drug resistance driven by cancer stem cells and their niche (English)
0 references
2574-
0 references
Kohama I
0 references
Ochiya T
0 references
